- Home
- SNES vs CYTO Comparison
SNES vs CYTO Comparison
Compare SNES & CYTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNES
- CYTO
- Stock Information
- Founded
- SNES 2004
- CYTO 2003
- Country
- SNES United States
- CYTO Bermuda
- Employees
- SNES N/A
- CYTO N/A
- Industry
- SNES Agricultural Chemicals
- CYTO Biotechnology: Pharmaceutical Preparations
- Sector
- SNES Industrials
- CYTO Health Care
- Exchange
- SNES Nasdaq
- CYTO Nasdaq
- Market Cap
- SNES 2.3M
- CYTO 2.0M
- IPO Year
- SNES 2016
- CYTO N/A
- Fundamental
- Price
- SNES $3.16
- CYTO $0.41
- Analyst Decision
- SNES Strong Buy
- CYTO
- Analyst Count
- SNES 1
- CYTO 0
- Target Price
- SNES $10.00
- CYTO N/A
- AVG Volume (30 Days)
- SNES 311.7K
- CYTO 182.2K
- Earning Date
- SNES 11-12-2024
- CYTO 09-24-2024
- Dividend Yield
- SNES N/A
- CYTO N/A
- EPS Growth
- SNES N/A
- CYTO N/A
- EPS
- SNES N/A
- CYTO N/A
- Revenue
- SNES $1,651,000.00
- CYTO N/A
- Revenue This Year
- SNES $91.45
- CYTO N/A
- Revenue Next Year
- SNES $101.31
- CYTO N/A
- P/E Ratio
- SNES N/A
- CYTO N/A
- Revenue Growth
- SNES 38.16
- CYTO N/A
- 52 Week Low
- SNES $1.90
- CYTO $0.40
- 52 Week High
- SNES $21.40
- CYTO $3.60
- Technical
- Relative Strength Index (RSI)
- SNES 56.47
- CYTO 43.48
- Support Level
- SNES $2.32
- CYTO $0.40
- Resistance Level
- SNES $5.00
- CYTO $0.58
- Average True Range (ATR)
- SNES 0.52
- CYTO 0.06
- MACD
- SNES 0.13
- CYTO 0.00
- Stochastic Oscillator
- SNES 35.66
- CYTO 17.14
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About CYTO Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.